BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24586281)

  • 21. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
    Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
    Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
    Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Boamah I; Adu-Gyamfi C; Asare I; Hesse IF; Mensah G
    BMC Infect Dis; 2008 Mar; 8():33. PubMed ID: 18328097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
    Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Rodríguez-Ramírez S; Sierra-Madero J; Beyrer C
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework.
    Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C
    Addiction; 2023 Jun; 118(6):1153-1160. PubMed ID: 36683132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
    Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM
    J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.
    Crowley D; Van Hout MC; Murphy C; Kelly E; Lambert JS; Cullen W
    Health Justice; 2018 Dec; 6(1):23. PubMed ID: 30569249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of telehealth to increase treatment access for prisoners with chronic hepatitis C.
    Halder A; Li VG; Sebastian M; Nazareth S; Tuma R; Cheng W; Doyle A
    Intern Med J; 2021 Aug; 51(8):1344-1347. PubMed ID: 34423535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquiring hepatitis C in prison: the social organisation of injecting risk.
    Treloar C; McCredie L; Lloyd AR;
    Harm Reduct J; 2015 Apr; 12():10. PubMed ID: 25903401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing assessment and treatment of hepatitis C in the custodial setting.
    Post JJ; Arain A; Lloyd AR
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
    Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
    BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prisoners' experience and perceptions of health care in Australian prisons: a qualitative study.
    Capon A; McGowan L; Bowman J
    Int J Prison Health; 2020 May; 16(3):249-262. PubMed ID: 33634663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
    Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
    Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
    J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
    Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
    Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C).
    Rance J; Lafferty L; Treloar C;
    Addiction; 2021 Oct; 116(10):2761-2769. PubMed ID: 33751739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
    Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
    Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk for acute hepatitis C infection during imprisonment in Australia.
    Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson W; Kaldor J; Lloyd A; Haber P
    Eur J Epidemiol; 2010 Feb; 25(2):143-8. PubMed ID: 20084429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.